2 February 2021
J A Kemp Webinar: SPCs – Update on Recent Political and Legal Developments
A Supplementary Protection Certificate (SPC) is a unique intellectual property right for active ingredients of human and veterinary medicinal products requiring marketing authorisation. Its purpose is to compensate patent holders for loss in effective patent term resulting from the time taken to receive such marketing authorisation. SPCs are available in EU/EEA member states, and other European countries including Switzerland and the UK, which (at least for now) broadly follows the legal framework set by EU regulation. This regulation specifies only four basic requirements for grant of an SPC, but each has provoked multiple referrals to the CJEU. The complex and...
Read morekeyboard_arrow_right
